Detalhe da pesquisa
1.
Reproducibility and predictive value of scoring stromal tumour infiltrating lymphocytes in triple-negative breast cancer: a multi-institutional study.
Breast Cancer Res Treat
; 171(1): 1-9, 2018 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-29774470
2.
A Review on Manufacturing Processes of Biocomposites Based on Poly(α-Esters) and Bioactive Glass Fillers for Bone Regeneration.
Biomimetics (Basel)
; 8(1)2023 Feb 14.
Artigo
Inglês
| MEDLINE | ID: mdl-36810412
3.
ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its Limitations.
Cancers (Basel)
; 15(4)2023 Feb 14.
Artigo
Inglês
| MEDLINE | ID: mdl-36831541
4.
HER2 blockade in metastatic collecting duct carcinoma (CDC) of the kidney: a case report.
Onkologie
; 35(12): 776-9, 2012.
Artigo
Inglês
| MEDLINE | ID: mdl-23207624
5.
Adenoid cystic carcinoma and basaloid carcinoma of the breast: A clinicopathological study.
Rev Esp Patol
; 54(4): 242-249, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34544554
6.
Model Composites Based on Poly(lactic acid) and Bioactive Glass Fillers for Bone Regeneration.
Polymers (Basel)
; 13(17)2021 Sep 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34503031
7.
Intra-Tumour Heterogeneity Is One of the Main Sources of Inter-Observer Variation in Scoring Stromal Tumour Infiltrating Lymphocytes in Triple Negative Breast Cancer.
Cancers (Basel)
; 13(17)2021 Aug 31.
Artigo
Inglês
| MEDLINE | ID: mdl-34503219
8.
Risk of Exclusion in People with Disabilities in Spain: Determinants of Health and Poverty.
Int J Environ Res Public Health
; 15(10)2018 09 27.
Artigo
Inglês
| MEDLINE | ID: mdl-30262774
9.
Is Regression after Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer Different in Sentinel and Non-sentinel Nodes?
Pathol Oncol Res
; 24(1): 167-170, 2018 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-28391512
10.
Analysis of the pathologic response to primary chemotherapy in patients with locally advanced breast cancer grouped according to estrogen receptor, progesterone receptor, and HER2 status.
Clin Breast Cancer
; 7(7): 559-64, 2007 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-17509165
11.
Predictive and Prognostic Brain Metastases Assessment in Luminal Breast Cancer Patients: FN14 and GRP94 from Diagnosis to Prophylaxis.
Front Oncol
; 7: 283, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-29250484
12.
Relationship between the method of detection and prognostic factors for breast cancer in a community with a screening programme.
J Med Screen
; 13(4): 183-91, 2006.
Artigo
Inglês
| MEDLINE | ID: mdl-17217607
13.
FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies.
Oncotarget
; 6(42): 44254-73, 2015 Dec 29.
Artigo
Inglês
| MEDLINE | ID: mdl-26497551
14.
[Nephrotic proteinuria in hypertensive nephrosclerosis: clinical and evolution characteristics]. / Proteinuria de tipo nefrótico en la nefroangioesclerosis hipertensiva: características clínicas y evolutivas.
Med Clin (Barc)
; 143(9): 392-4, 2014 Nov 07.
Artigo
Espanhol
| MEDLINE | ID: mdl-24229808
15.
The great mimicker: fat necrosis of the breast--magnetic resonance mammography approach.
Curr Probl Diagn Radiol
; 38(4): 189-97, 2009.
Artigo
Inglês
| MEDLINE | ID: mdl-19464588
16.
Guidelines for HER2 testing in breast cancer: a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM).
Clin Transl Oncol
; 11(6): 363-75, 2009 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-19531451
17.
Interval breast cancers in a community screening programme: frequency, radiological classification and prognostic factors.
Eur J Cancer Prev
; 17(5): 414-21, 2008 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-18714182
18.
Proteinuria de tipo nefrótico en la nefroangioesclerosis hipertensiva: características clínicas y evolutivas / Nephrotic proteinuria in hypertensive nephrosclerosis: Clinical and evolution characteristics
Med. clín (Ed. impr.)
; 143(9): 392-394, nov. 2014. tab
Artigo
Espanhol
| IBECS (Espanha) | ID: ibc-128399
19.
Recomendación para la determinación de HER2 en cáncer de mama. Consenso nacional de la Sociedad Españolade Anatomía Patológica (SEAP) y de la SociedadEspañola de Oncología Médica (SEOM) / Guidelines for HER2 testing in breast cancer. A national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
Rev. esp. patol
; 42(1): 3-16, ene.-mar. 2009. ilus, graf, tab
Artigo
Espanhol
| IBECS (Espanha) | ID: ibc-61018
20.
Carcinoma microinvasivo de mama: estudio clinicopatológico de 18 casos / Microinvasive breast carcinoma: a clinicopathological profile of 18 cases
Rev. esp. patol
; 41(2): 109-116, abr.-jun. 2008. ilus, tab
Artigo
Es
| IBECS (Espanha) | ID: ibc-68295